The effects of the partial government shutdown in the US on science keep spreading.
Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.
According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.
ScienceInsider describes the effects of the partial government shutdown in the US on science.
Kelvin Droegemeier has been confirmed by the Senate as director of the White House Office of Science and Technology Policy, Stat News reports.
A Senate committee voted unanimously yesterday to approve Kelvin Droegemeier as science advisor, Nature News reports.
Science has drawn up a list of topics to discuss with Kelvin Droegemeier, the nominee to direct the White House Office of Science and Technology Policy.
The Washington Post reports that President Donald Trump is to nominate Kelvin Droegemeier to be the White House science and technology advisor.
With recent challenges to the US Affordable Care Act, NPR looks into whether there are any ramifications for genetic privacy.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.
US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.
Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.
In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.